Aethlon Medical Elevates James B. Frakes to Permanent Chief Executive Officer
PUBLIC · AEMDOct 03, 2024
Company
Aethlon Medical
San DiegoBiotechnologyHealth CareMedicalTherapeutics
Description
Aethlon Medical, Inc has elevated James B Frakes from Interim to permanent Chief Executive Officer, while retaining his roles as Chief Financial Officer and Board member. Guy F Cipriani has amicably stepped down as Chief Operating Officer.
Company Information
Company
Aethlon Medical
Location
San Diego, California, United States
About
Aethlon Medical is a medical therapeutic company focused on developing the Hemopurifier, a clinical stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. In human studies, the Hemopurifier has demonstrated the removal of life-threatening viruses and harmful exosomes from blood utilizing its proprietary lectin-based technology. This action has potential applications in cancer, where exosomes may promote immune suppression and metastasis, and in life-threatening infectious diseases. The Hemopurifier is a U.S. Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption (IDE) application related to the treatment of life-threatening viruses that are not addressed with approved therapies.
Additional information can be found at www.AethlonMedical.com.
Fundz sees it the moment Aethlon Medical changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
San DiegoBiotechnologyHealth CareMedicalTherapeutics